134 related articles for article (PubMed ID: 15706638)
1. Scaling the biobusiness information mountain.
Williams G; Walsh G
Nat Biotechnol; 2005 Jan; 23(1):147-9. PubMed ID: 15706638
[No Abstract] [Full Text] [Related]
2. Biobusiness on the Web.
Frederickson RM
Nat Biotechnol; 2003 May; 21(5):499-503. PubMed ID: 12721572
[No Abstract] [Full Text] [Related]
3. Building for an exit (or not).
Gunning TG
Nat Biotechnol; 2008 Sep; 26(9):971-3. PubMed ID: 18792427
[TBL] [Abstract][Full Text] [Related]
4. Andrew Gearing. Interview by Suzanne Berry.
Berry S
Trends Biotechnol; 2002 Sep; 20(9):404-5. PubMed ID: 12175773
[No Abstract] [Full Text] [Related]
5. Sunbaked biotechnology in Australia.
Littlejohn T
Nat Biotechnol; 2002 Sep; 20(9):873-7. PubMed ID: 12205502
[No Abstract] [Full Text] [Related]
6. Spin-offs versus start-ups as business models in biotechnology.
Persidis A; De Rubertis F
Nat Biotechnol; 2000 May; 18(5):570-1. PubMed ID: 10802637
[No Abstract] [Full Text] [Related]
7. Realizing potential: the state of Asian bioentrepreneurship.
Tang CM; Mahmud MA; Foo FK; Chu SY; Chiu RI; Tanticharoen M; Zhang L; Chang TW
Nat Biotechnol; 2003 Jul; 21 Suppl():BE15-22. PubMed ID: 12874972
[No Abstract] [Full Text] [Related]
8. Enthusiasm cools in Q2.
Lawrence S
Nat Biotechnol; 2005 Aug; 23(8):914. PubMed ID: 16082352
[No Abstract] [Full Text] [Related]
9. Shutters come off IPO window.
Hodgson J
Nat Biotechnol; 2002 Jan; 20(1):6. PubMed ID: 11753342
[No Abstract] [Full Text] [Related]
10. Bioentrepreneurship around the world.
Persidis A
Nat Biotechnol; 1998 May; 16 Suppl():3-4. PubMed ID: 9591247
[No Abstract] [Full Text] [Related]
11. China's biotech experiments.
Hepeng J
Nat Biotechnol; 2005 Dec; 23(12):1472-3. PubMed ID: 16421994
[No Abstract] [Full Text] [Related]
12. Big pharma wants you.
Mack GS
Nat Biotechnol; 2006 Nov; 24(11):1317-9. PubMed ID: 17162751
[TBL] [Abstract][Full Text] [Related]
13. The business of making vaccines.
Sheridan C
Nat Biotechnol; 2005 Nov; 23(11):1359-66. PubMed ID: 16273061
[TBL] [Abstract][Full Text] [Related]
14. Divining the path to a successful European exit.
Buch HK; Gustafsson AC; Drvota V; Sundberg CJ
Nat Biotechnol; 2011 Mar; 29(3):205-7. PubMed ID: 21510008
[No Abstract] [Full Text] [Related]
15. Michigan's next wave of biopharmaceutical entrepreneurship.
Kerppola R; van de Walle M; Surine S
Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575
[No Abstract] [Full Text] [Related]
16. Crystal gazing: biotech's financial outlook: the biotech analyst's view.
Schmidt E
Nat Biotechnol; 2006 Mar; 24(3):261-2. PubMed ID: 16525376
[No Abstract] [Full Text] [Related]
17. Crystal gazing: biotech's financial outlook: the investment banker's view.
Strupp DJ
Nat Biotechnol; 2006 Mar; 24(3):263-4. PubMed ID: 16525375
[No Abstract] [Full Text] [Related]
18. A primer for website design.
Dysart J
Nat Biotechnol; 2003 Jul; 21 Suppl():BE55-8. PubMed ID: 12874983
[No Abstract] [Full Text] [Related]
19. Designs that enrich lives.
Link A; Stark H
Arch Pharm (Weinheim); 2007 Oct; 340(10):509-10. PubMed ID: 17912676
[No Abstract] [Full Text] [Related]
20. Pharmas partner in venture seeking drug discovery tools.
Mack GS
Nat Biotechnol; 2008 Sep; 26(9):960-1. PubMed ID: 18779790
[No Abstract] [Full Text] [Related]
[Next] [New Search]
